Q1. How many patients were treated in last 4 months by the Dermatology department with each of the following:
- Abrocitinib- 0 active patients on homecare
- Acitretin- 140 patients between 01/08/2022-30/11/2022
- Alitretinoin- 20 patients between 01/08/2022-30/11/2022
- Azathioprine- The Trusts systems are unable to delineate dermatology patients
- Baricitinib- <5 active patient on homecare
- Ciclosporin- The Trusts systems are unable to delineate dermatology patients
- Dupilumab- 114 active patients on homecare
- Methotrexate- 19 active patients on subcutaneous methotrexate. The Trusts systems are unable to delineate dermatology patients for oral methotrexate
- Mycophenolate mofetil- The Trusts systems are unable to delineate dermatology patients
- Pimecrolimus- 26 patients between 01/08/2022-30/11/2022
- Tacrolimus ointment- 102 patients between 01/08/2022-30/11/2022
- Tralokinumab- 9 active patients on homecare
- Upadacitinib- <5 active patient on homecare
- Phototherapy (UVB or PUVA)- See table below:-
|
Age
|
Number of patients in last 4 months
|
|
Burnley
|
Blackburn
|
|
6-11
|
<5
|
<5
|
|
12-17
|
<5
|
<5
|
|
18+
|
28
|
17
|
|
number of patients treated for atopic dermatitis/eczema
|
15
|
11
|
Q2. Of the patients treated in the last 4 months with any of the products listed in Q1, please provide the number of patients by the following age-groups:
- Age 6-11
-Acitretin- <5
-Alitretinoin- 0
-Pimecrolimus- 0
-Tacrolimus- 10
-Acitretin- <5
-Alitretinoin- 0
-Pimecrolimus- <5
-Tacrolimus- 12
-Acitretin- 135
-Alitretinoin- 20
-Pimecrolimus- 19
-Tacrolimus- 74
All patients listed for homecare treatments (denoted by described as being the number of 'active patients' in question 1 are above 18 years old.
Q3. If possible, could you please provide the number of patients treated in the last 4 months for atopic dermatitis ONLY with:
- Azathioprine- The Trusts systems are unable to delineate AD patients
- Ciclosporin- The Trusts systems are unable to delineate AD patients
- Methotrexate- unable to delineate AD patients on oral methotrexate. There are 5 homecare patients on subcutaneous methotrexate for AD
- Mycophenolate mofetil- The Trusts systems are unable to delineate AD patients
- Phototherapy (UVB or PUVA)- See Table below: -
|
Age
|
Number of patients in last 4 months
|
|
Burnley
|
Blackburn
|
|
6-11
|
<5
|
<5
|
|
12-17
|
<5
|
<5
|
|
18+
|
28
|
17
|
|
number of patients treated for atopic dermatitis/eczema
|
15
|
11
|
